MetLife Investment Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,464
| Closed | -$55.6K | – | 2999 |
|
|
2023
Q2 | $55.6K | Buy |
21,464
+13,459
| +168% | +$34.9K | ﹤0.01% | 2889 |
|
|
2023
Q1 | $32.7K | Sell |
8,005
-10,296
| -56% | -$42K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $91.9K | Hold |
18,301
| – | – | ﹤0.01% | 2626 |
|
|
2022
Q3 | $239K | Hold |
18,301
| – | – | ﹤0.01% | 2166 |
|
|
2022
Q2 | $235K | Hold |
18,301
| – | – | ﹤0.01% | 2202 |
|
|
2022
Q1 | $279K | Buy |
18,301
+6,636
| +57% | +$101K | ﹤0.01% | 2136 |
|
|
2021
Q4 | $207K | Hold |
11,665
| – | – | ﹤0.01% | 2032 |
|
|
2021
Q3 | $245K | Hold |
11,665
| – | – | ﹤0.01% | 1960 |
|
|
2021
Q2 | $230K | Hold |
11,665
| – | – | ﹤0.01% | 2073 |
|
|
2021
Q1 | $339K | Hold |
11,665
| – | – | ﹤0.01% | 1744 |
|
|
2020
Q4 | $353K | Hold |
11,665
| – | – | ﹤0.01% | 1667 |
|
|
2020
Q3 | $186K | Hold |
11,665
| – | – | ﹤0.01% | 1906 |
|
|
2020
Q2 | $230K | Hold |
11,665
| – | – | ﹤0.01% | 1819 |
|
|
2020
Q1 | $144K | Hold |
11,665
| – | – | ﹤0.01% | 1875 |
|
|
2019
Q4 | $216K | Buy |
+11,665
| New | +$216K | ﹤0.01% | 1936 |
|